Diagnosis and treatment of nontuberculous mycobacterial lung disease

Journal of the Korean Medical Association

Volumn 54, Issue 10, 2011, Pages 1053-1058

  Koh, Won Jung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Mycobacterium abscessus; Mycobacterium avium complex; Nontuberculous mycobacteria

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN;

ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BRONCHIECTASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE COURSE; DRUG EFFICACY; HUMAN; LUNG CAVITATION; LUNG INFECTION; LUNG NODULE; LUNG SURGERY; MEDICAL DECISION MAKING; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; NONHUMAN; NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE; PATIENT ASSESSMENT; TREATMENT INDICATION;

EID: 80054905888     PISSN: 19758456     EISSN: None     Source Type: Journal    
DOI: 10.5124/jkma.2011.54.10.1053     Document Type: Article

References (17)

1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K; ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treat-ment, and prevention of nontuberculous mycobacterial disea-ses. Am J Respir Crit Care Med 2007;175:367-416. (Pubitemid 46271561)
2. Koh WJ, Kwon OJ, Lee KS. Diagnosis and treatment of nontu-berculous mycobacterial pulmonary diseases: a Korean pers-pective. J Korean Med Sci 2005;20:913-925. (Pubitemid 43161852)
3. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, Bai GH. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006;129:341-348. (Pubitemid 43289853)
4. Park YS, Lee CH, Lee SM, Yang SC, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ. Rapid increase of non-tuberculous mycobac-terial lung diseases at a tertiary referral hospital in South Korea. Int J Tuberc Lung Dis 2010;14:1069-1071.
5. Daley CL, Griffith DE. Pulmonary non-tuberculous myco-bacterial infections. Int J Tuberc Lung Dis 2010;14:665-671.
6. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Associa-tion. Am J Respir Crit Care Med 1997;156(2 Pt 2):S1-S25.
7. Lam PK, Griffith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, Catanzaro A. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006;173:1283-1289. (Pubitemid 43848401)
8. Griffith DE, Brown-Elliott BA, Shepherd S, McLarty J, Griffith L, Wallace RJ Jr. Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2005;172:250-253. (Pubitemid 40981202)
9. Hasegawa N, Nishimura T, Ohtani S, Takeshita K, Fukunaga K, Tasaka S, Urano T, Ishii K, Miyairi M, Ishizaka A. Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease. Chest 2009;136:1569-1575.
10. Kim EY, Chi SY, Oh IJ, Kim KS, Kim YI, Lim SC, Kim YC, Kwon YS. Treatment outcome of combination therapy including clarithromycin for Mycobacterium avium complex pulmonary disease. Korean J Intern Med 2011;26:54-59.
11. Field SK, Fisher D, Cowie RL. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 2004;126:566-581. (Pubitemid 39093445)
12. Jeon K, Kwon OJ, Lee NY, Kim BJ, Kook YH, Lee SH, Park YK, Kim CK, Koh WJ. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 pa-tients. Am J Respir Crit Care Med 2009;180:896-902.
13. Jarand J, Levin A, Zhang L, Huitt G, Mitchell JD, Daley CL. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis 2011;52:565-571.
14. Lyu J, Jang HJ, Song JW, Choi CM, Oh YM, Lee SD, Kim WS, Kim DS, Shim TS. Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs. Respir Med 2011;105:781-787.
15. Kim HY, Kook Y, Yun YJ, Park CG, Lee NY, Shim TS, Kim BJ, Kook YH. Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates. J Clin Microbiol 2008;46:3384-3390.
16. Nash KA, Brown-Elliott BA, Wallace RJ Jr. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother 2009;53:1367-1376.
17. Koh WJ, Jeon K, Lee NY, Kim BJ, Kook YH, Lee SH, Park YK, Kim CK, Shin SJ, Huitt GA, Daley CL, Kwon OJ. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med 2011;183:405-410.